IDEXX LABORATORIES INC /DE Payments To Acquire Equity Securities Fv Ni
IDEXX LABORATORIES INC /DE (IDXX) reported Payments To Acquire Equity Securities Fv Ni of $799.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireEquitySecuritiesFvNi · last filed 2026-08-04
- IDEXX LABORATORIES INC /DE payments to acquire equity securities fv ni for the quarter ending 2026-06-30 was $0.00.
- IDEXX LABORATORIES INC /DE payments to acquire equity securities fv ni for the quarter ending 2026-03-31 was $799.00K.
- IDEXX LABORATORIES INC /DE payments to acquire equity securities fv ni for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- IDEXX LABORATORIES INC /DE payments to acquire equity securities fv ni for the quarter ending 2025-09-30 was $756.00K.
- IDEXX LABORATORIES INC /DE payments to acquire equity securities fv ni for fiscal 2025 was $756.00K, a 24.70% decline from fiscal 2024.
- IDEXX LABORATORIES INC /DE payments to acquire equity securities fv ni for fiscal 2024 was $1.00M.
- IDEXX LABORATORIES INC /DE payments to acquire equity securities fv ni for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- IDEXX LABORATORIES INC /DE payments to acquire equity securities fv ni for fiscal 2022 was $25.00M.
| Period end | Payments To Acquire Equity Securities Fv Ni 3 month | Payments To Acquire Equity Securities Fv Ni 6 month | Payments To Acquire Equity Securities Fv Ni 9 month | Payments To Acquire Equity Securities Fv Ni 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $799.00K 10-Q · filed 2026-08-04 | $799.00K derived: sum of 3 quarters · filed 2026-08-04 | $1.55M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $799.00K 10-Q · filed 2026-05-05 | $799.00K derived: sum of 2 quarters · filed 2026-05-05 | $1.55M derived: sum of 3 quarters · filed 2026-05-05 | $1.55M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $756.00K derived: sum of 2 quarters · filed 2026-02-20 | $756.00K derived: sum of 3 quarters · filed 2026-08-04 | $756.00K 10-K · filed 2026-02-20 |
| 2025-09-30 | $756.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $756.00K derived: sum of 2 quarters · filed 2026-08-04 | $756.00K 10-Q · filed 2025-11-03 | $1.76M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $0.00 10-Q · filed 2026-08-04 | $1.00M derived: sum of 3 quarters · filed 2026-08-04 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-05 | $1.00M derived: sum of 2 quarters · filed 2026-05-05 | ||
| 2024-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $1.00M 10-K · filed 2026-02-20 | ||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-03 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $0.00 derived: sum of 2 quarters · filed 2026-02-20 | $0.00 10-K · filed 2026-02-20 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $0.00 10-Q · filed 2023-11-01 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-01 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $0.00 derived: sum of 2 quarters · filed 2025-02-21 | $25.00M derived: sum of 3 quarters · filed 2025-02-21 | $25.00M 10-K · filed 2025-02-21 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $25.00M derived: sum of 2 quarters · filed 2023-11-01 | $25.00M 10-Q · filed 2023-11-01 | |
| 2022-06-30 | $25.00M 10-Q · filed 2023-11-01 | $25.00M 10-Q · filed 2023-08-01 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $0.00 derived: sum of 2 quarters · filed 2024-02-22 | $0.00 10-K · filed 2024-02-22 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $0.00 10-Q · filed 2022-11-01 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-02 | |||
| 2020-12-31 | $250.00K 10-K · filed 2023-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |